HK1141788A1 - Novel heterocyclic compounds as mglu5 antagonists - Google Patents
Novel heterocyclic compounds as mglu5 antagonistsInfo
- Publication number
- HK1141788A1 HK1141788A1 HK10107247.4A HK10107247A HK1141788A1 HK 1141788 A1 HK1141788 A1 HK 1141788A1 HK 10107247 A HK10107247 A HK 10107247A HK 1141788 A1 HK1141788 A1 HK 1141788A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- heterocyclic compounds
- novel heterocyclic
- mglu5 antagonists
- treatment
- mglu5
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95367707P | 2007-08-02 | 2007-08-02 | |
| US4517508P | 2008-04-15 | 2008-04-15 | |
| PCT/EP2008/006351 WO2009015897A1 (en) | 2007-08-02 | 2008-08-01 | Novel heterocyclic compounds as mglu5 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1141788A1 true HK1141788A1 (en) | 2010-11-19 |
Family
ID=39885225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK10107247.4A HK1141788A1 (en) | 2007-08-02 | 2010-07-28 | Novel heterocyclic compounds as mglu5 antagonists |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8518916B2 (pt) |
| EP (1) | EP2178858B1 (pt) |
| JP (1) | JP5412430B2 (pt) |
| KR (1) | KR20100052507A (pt) |
| CN (1) | CN101821256A (pt) |
| AT (1) | ATE539075T1 (pt) |
| AU (1) | AU2008282032B2 (pt) |
| BR (1) | BRPI0814182A2 (pt) |
| CA (1) | CA2694359A1 (pt) |
| CY (1) | CY1112500T1 (pt) |
| DK (1) | DK2178858T3 (pt) |
| EA (1) | EA018328B1 (pt) |
| ES (1) | ES2380165T3 (pt) |
| HK (1) | HK1141788A1 (pt) |
| HR (1) | HRP20120225T1 (pt) |
| IL (1) | IL203659A (pt) |
| NZ (1) | NZ582934A (pt) |
| PL (1) | PL2178858T3 (pt) |
| PT (1) | PT2178858E (pt) |
| RS (1) | RS52167B (pt) |
| SI (1) | SI2178858T1 (pt) |
| WO (1) | WO2009015897A1 (pt) |
| ZA (1) | ZA201001467B (pt) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8937148B2 (en) | 2012-09-07 | 2015-01-20 | Empire Technology Development LLP | Regioregular copolymers and methods for making same |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100317630A1 (en) * | 2009-02-04 | 2010-12-16 | Recordati Ireland Limited | Novel heterocyclic compounds as mglu5 antagonists |
| WO2011029633A1 (en) * | 2009-09-14 | 2011-03-17 | Recordati Ireland Limited | Heterocyclic mglu5 antagonists |
| WO2012085166A1 (en) * | 2010-12-22 | 2012-06-28 | Merz Pharma Gmbh & Co. Kgaa | Metabotropic glutamate receptor modulators |
| WO2012085167A1 (en) * | 2010-12-22 | 2012-06-28 | Merz Pharma Gmbh & Co. Kgaa | Metabotropic glutamate receptor modulators |
| KR101983421B1 (ko) * | 2011-12-27 | 2019-05-29 | 디에스엠 아이피 어셋츠 비.브이. | 비타민 a 중간체의 촉매 합성법 |
| CN102827056B (zh) * | 2012-09-03 | 2014-07-23 | 华东理工大学 | N-芳基取代吡咯烷酮衍生物及其用途 |
| WO2014117919A1 (en) * | 2013-02-04 | 2014-08-07 | Merck Patent Gmbh | Positive allosteric modulators of mglur3 |
| BR112019027922A2 (pt) * | 2017-06-29 | 2020-08-18 | Recordati Industria Chimica E Farmaceutica Spa | derivados de heterociclilmetilideno e uso dos mesmos como moduladores de receptores de mglur5 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE24826E (en) * | 1956-08-30 | 1960-05-17 | N-alkylpiperidyl alkynylamines | |
| JPS5995249A (ja) * | 1982-11-24 | 1984-06-01 | Ono Pharmaceut Co Ltd | ロイコトリエンｂ４類似化合物、その製造方法及びそれらを有効成分として含有する治療剤 |
| CA2080536A1 (en) * | 1991-10-17 | 1993-04-18 | John S. Ward | Nicotinic activity of a series of arecolones and isoarecolones |
| US5990114A (en) | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
| KR20020005653A (ko) * | 1999-04-01 | 2002-01-17 | 실버스타인 아써 에이. | 소르비톨 디하이드로게나제 저해제로서의 아미노피리미딘 |
| US6265434B1 (en) * | 1999-04-06 | 2001-07-24 | Merck & Co., Inc. | Pyrrolidine modulators of chemokine receptor activity |
| TW593241B (en) | 1999-04-20 | 2004-06-21 | Hoffmann La Roche | Carbamic acid derivatives |
| ITMI991452A1 (it) * | 1999-07-01 | 2001-01-01 | Mediolanum Farmaceutici Srl | Antagonisti selettivi per i recettori m2 con struttura 5h-dibenzo b,fazepinica |
| US6387909B1 (en) | 1999-07-30 | 2002-05-14 | Recordati S.A. Chemical And Pharmaceutical Company | Thienopyranecarboxamide derivatives |
| US6306861B1 (en) | 1999-07-30 | 2001-10-23 | Recordati S.A. Chemical And Pharmaceutical Company | Thienopyrancecarboxamide derivatives |
| US6548522B1 (en) | 1999-10-12 | 2003-04-15 | Hoffmann-La Roche Inc. | Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives |
| US6365591B1 (en) | 1999-10-18 | 2002-04-02 | Recordati, S.A., Chemical And Pharmacueticals Company | Isoxazolecarboxamide derivatives |
| US6403594B1 (en) | 1999-10-18 | 2002-06-11 | Recordati, S.A. Chemical And Pharmaceutical Company | Benzopyran derivatives |
| AU1071301A (en) | 1999-11-01 | 2001-05-14 | Eli Lilly And Company | Pharmaceutical compounds |
| PT1294358E (pt) | 2000-06-28 | 2004-12-31 | Smithkline Beecham Plc | Processo de moagem por via humida |
| US6369222B1 (en) | 2000-07-18 | 2002-04-09 | Hoffmann-La Roche Inc. | mGluR antagonists and a method for their synthesis |
| WO2003093236A1 (en) * | 2002-05-02 | 2003-11-13 | Euro-Celtique, S.A. | 1-(pyrid-2-yl)-piperazine compounds as metabotropic glutamate receptor inhibitor |
| US7348337B2 (en) * | 2002-05-28 | 2008-03-25 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| PT1539739E (pt) * | 2002-08-16 | 2011-01-05 | Janssen Pharmaceutica Nv | Compostos de piperidinilo que ligam selectivamente integrinas |
| US7491737B2 (en) | 2002-10-30 | 2009-02-17 | Merck & Co., Inc. | Heterarylpiperidine modulators of chemokine receptor activity |
| US7572922B2 (en) * | 2003-01-27 | 2009-08-11 | Merck & Co., Inc. | Substituted pyrazoles, compositions containing such compounds and methods of use |
| ITMI20030151A1 (it) | 2003-01-30 | 2004-07-31 | Recordati Ind Chimica E Farma Ceutica S P A | Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore. |
| US7338954B2 (en) * | 2003-09-17 | 2008-03-04 | Bristol-Myers Squibb Company | Compounds useful as motilin agonists and method |
| FR2866884B1 (fr) * | 2004-02-26 | 2007-08-31 | Sanofi Synthelabo | Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique |
| EP1740556A1 (en) | 2004-03-26 | 2007-01-10 | Rigel Pharmaceuticals, Inc. | Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| JP2007531729A (ja) * | 2004-04-02 | 2007-11-08 | アデノシン、セラピューティックス、リミテッド、ライアビリティ、カンパニー | Ａ２ａアデノシンレセプターの選択的アンタゴニスト |
| GB0503646D0 (en) * | 2005-02-22 | 2005-03-30 | Novartis Ag | Organic compounds |
| AU2006228957A1 (en) * | 2005-04-01 | 2006-10-05 | Methylgene Inc. | Inhibitors of histone deacetylase |
| GB0514296D0 (en) * | 2005-07-12 | 2005-08-17 | Novartis Ag | Organic compounds |
| CA2627722A1 (en) * | 2005-10-31 | 2007-06-21 | Merck & Co., Inc. | Cetp inhibitors |
| EP2007720B1 (en) * | 2006-04-07 | 2013-12-25 | MethylGene Inc. | Benzamide derivatives as inhibitors of histone deacetylase |
| US7985754B2 (en) | 2006-07-17 | 2011-07-26 | Trovis Pharmaceuticals, Llc | Selective antagonists of A2A adenosine receptors |
-
2008
- 2008-08-01 WO PCT/EP2008/006351 patent/WO2009015897A1/en active Application Filing
- 2008-08-01 CN CN200880101389A patent/CN101821256A/zh active Pending
- 2008-08-01 DK DK08785292.7T patent/DK2178858T3/da active
- 2008-08-01 JP JP2010518567A patent/JP5412430B2/ja not_active Expired - Fee Related
- 2008-08-01 KR KR1020107004641A patent/KR20100052507A/ko not_active Application Discontinuation
- 2008-08-01 ES ES08785292T patent/ES2380165T3/es active Active
- 2008-08-01 NZ NZ582934A patent/NZ582934A/en not_active IP Right Cessation
- 2008-08-01 EP EP08785292A patent/EP2178858B1/en active Active
- 2008-08-01 PT PT08785292T patent/PT2178858E/pt unknown
- 2008-08-01 AT AT08785292T patent/ATE539075T1/de active
- 2008-08-01 PL PL08785292T patent/PL2178858T3/pl unknown
- 2008-08-01 RS RS20120110A patent/RS52167B/en unknown
- 2008-08-01 CA CA2694359A patent/CA2694359A1/en not_active Abandoned
- 2008-08-01 SI SI200830533T patent/SI2178858T1/sl unknown
- 2008-08-01 EA EA201000283A patent/EA018328B1/ru not_active IP Right Cessation
- 2008-08-01 BR BRPI0814182-7A2A patent/BRPI0814182A2/pt not_active IP Right Cessation
- 2008-08-01 AU AU2008282032A patent/AU2008282032B2/en not_active Expired - Fee Related
- 2008-08-04 US US12/185,639 patent/US8518916B2/en not_active Expired - Fee Related
-
2010
- 2010-02-02 IL IL203659A patent/IL203659A/en not_active IP Right Cessation
- 2010-03-01 ZA ZA2010/01467A patent/ZA201001467B/en unknown
- 2010-07-28 HK HK10107247.4A patent/HK1141788A1/xx not_active IP Right Cessation
-
2012
- 2012-03-12 HR HR20120225T patent/HRP20120225T1/hr unknown
- 2012-03-21 CY CY20121100296T patent/CY1112500T1/el unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8937148B2 (en) | 2012-09-07 | 2015-01-20 | Empire Technology Development LLP | Regioregular copolymers and methods for making same |
| US9181287B2 (en) | 2012-09-07 | 2015-11-10 | Empire Technology Development Llc | Regioregular copolymers and methods for making same |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2380165T3 (es) | 2012-05-09 |
| EA201000283A1 (ru) | 2010-06-30 |
| AU2008282032A1 (en) | 2009-02-05 |
| CY1112500T1 (el) | 2015-12-09 |
| JP2010535165A (ja) | 2010-11-18 |
| CA2694359A1 (en) | 2009-02-05 |
| ZA201001467B (en) | 2010-11-24 |
| EA018328B1 (ru) | 2013-07-30 |
| CN101821256A (zh) | 2010-09-01 |
| EP2178858A1 (en) | 2010-04-28 |
| KR20100052507A (ko) | 2010-05-19 |
| DK2178858T3 (da) | 2012-03-19 |
| NZ582934A (en) | 2011-10-28 |
| WO2009015897A1 (en) | 2009-02-05 |
| RS52167B (en) | 2012-08-31 |
| SI2178858T1 (sl) | 2012-03-30 |
| PL2178858T3 (pl) | 2012-07-31 |
| PT2178858E (pt) | 2012-02-24 |
| EP2178858B1 (en) | 2011-12-28 |
| BRPI0814182A2 (pt) | 2015-01-27 |
| AU2008282032B2 (en) | 2014-08-07 |
| ATE539075T1 (de) | 2012-01-15 |
| JP5412430B2 (ja) | 2014-02-12 |
| HRP20120225T1 (hr) | 2012-04-30 |
| IL203659A (en) | 2013-06-27 |
| US8518916B2 (en) | 2013-08-27 |
| US20090042841A1 (en) | 2009-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1141788A1 (en) | Novel heterocyclic compounds as mglu5 antagonists | |
| GEP20115140B (en) | Substituted spirocyclic cgrp receptor antagonists | |
| UA99620C2 (en) | Pyridyl piperidine orexin receptor antagonists | |
| ATE469895T1 (de) | Cgrp-rezeptorantagonisten | |
| MX2009005712A (es) | Antagonistas de receptor de orexina de diazepam sustituido. | |
| SI2049529T1 (sl) | Substituiran diazepan oreksin receptor antagonist | |
| WO2007126935A3 (en) | Diazepan orexin receptor antagonists | |
| WO2008008517A3 (en) | Bridged diazepan orexin receptor antagonists | |
| UA106873C2 (uk) | Сполуки заміщених діазепанів як антагоністи орексинових рецепторів | |
| TW200720260A (en) | Prokineticin 1 receptor antagonists | |
| TW200716566A (en) | Prokineticin 2 receptor antagonists | |
| TW200800959A (en) | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor | |
| WO2009005671A3 (en) | Substituted piperazines as cb1 antagonists | |
| WO2009005646A3 (en) | Substituted piperazines as cb1 antagonists | |
| WO2009020470A3 (en) | Cgrp receptor antagonists | |
| WO2007146349A3 (en) | Cgrp receptor antagonists | |
| MX2007004661A (es) | Derivados de 1-(hetero)aril-3-amino-pirrolidina para usarse como antagonistas del receptor mglur3. | |
| EA200801591A1 (ru) | Антагонисты мускаринового рецептора | |
| WO2007007281A3 (en) | Muscarinic receptor antagonists | |
| WO2008104942A3 (en) | Muscarinic receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160801 |